Long-term Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

PHASE3TerminatedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

January 31, 2011

Study Completion Date

March 31, 2011

Conditions
Type 2 Diabetes MellitusType 2 Diabetes
Interventions
DRUG

dutogliptin

dutogliptin 400 mg, once daily tablet

Trial Locations (68)

Unknown

Norwalk

Orange

Santa Ana

Daytona Beach

Kissimmee

Atlanta

Phenomix Investigational Site 663, Honolulu

Brockton

St Louis

Cincinnati

El Paso

San Antonio

Norfolk

Phenomix Investigational Site 103, Buenos Aires

Phenomix Investigational Site 110, Buenos Aires

Phenomix Investigational Site 111, Buenos Aires

Phenomix Investigational Site 106, Caba

Phenomix Investigational Site 112, Corrientes

Phenomix Investigational Site 102, Paraná

Bangalore, Karnataka

Chennai, Tamil Nadu

Gulbarga, Karnataka

Hyderabad, Andhara Pradesh

Mumbai, Maharashtra

Nagpur, Maharashtra

Nashik, Maharashtra

Navi Mumbai, Maharashtra

Pune, Maharashtra

Phenomix Investigational Site 403, Kuching

Kelantan

Kuala Lumpur

Perak

Phenomix Investigational Site 404, Putrajaya

Sarawak

Phenomix Investigational Site 604, Arequipa

Phenomix Investigational Site 606, Lambayeque

Phenomix Investigational Site 600, Lima

Phenomix Investigational Site 601, Lima

Phenomix Investigational Site 602, Lima

Phenomix Investigational Site 609, Lima

Phenomix Investigational Site 703, Cebu City

Manila, NCR

Quezon City, NCR

San Juan, NCR

Phenomix Investigational Site 802, Brasov

Phenomix Investigational Site 806, Brasov

Phenomix Investigational Site 800, Bucharest

Phenomix Investigational Site 803, Bucharest

Phenomix Investigational Site 805, Bucharest

Phenomix Investigational Site 807, Bucharest

Phenomix Investigational Site 804, Galati

Phenomix Investigational Site 801, Ploieşti

Phenomix Investigational Site 808, Sibiu

Phenomix Investigational Site 551, Ivano-Frankivsk

Phenomix Investigational Site 550, Kharkiv

Phenomix Investigational Site 557, Kharkiv

Phenomix Investigational Site 564, Kharkiv

Phenomix Investigational Site 555, Kiev

Phenomix Investigational Site 556, Kiev

Phenomix Investigational Site 562, Kiev

Phenomix Investigational Site 563, Kiev

Phenomix Investigational Site 554, Kylv

Phenomix Investigational Site 565, Lutsk

Phenomix Investigational Site 553, Lviv

Phenomix Investigational Site 561, Poltava

Phenomix Investigational Site 560, Simferopol

Phenomix Investigational Site 559, Vinnitsa

Phenomix Investigational Site 552, Zaporzhzhia

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

Phenomix

INDUSTRY